Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma

X Wei, X Wang, J Xiong, C Li, Y Liao… - BioMed Research …, 2022 - Wiley Online Library
… “papillary thyroid carcinoma OR PTC OR papillary thyroid microcarcinoma OR PTMC”.
Relevant articles were used to broaden the search scope, and all retrieved studies, reviews, and …

[HTML][HTML] Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review

FA Rashid, J Munkhdelger, J Fukuoka, A Bychkov - Gland Surgery, 2020 - ncbi.nlm.nih.gov
… almost 2.1% of newly diagnosed cancer cases (1). Papillary thyroid carcinoma (PTC) is
the most common histological type of differentiated thyroid carcinoma accounting for 75–85% …

BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence

S Enumah, A Fingeret, S Parangi… - World journal of …, 2020 - Wiley Online Library
… Our dataset included an unselected cohort of papillary thyroid carcinoma (PTC) patients
who underwent a total thyroidectomy (or unilateral then completion thyroidectomy) at a single …

The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma

RS Scheffel, AP Cristo, M Romitti… - … of endocrinology and …, 2020 - SciELO Brasil
Cancer Res 2003;63(7):1454-7.). … with papillary thyroid cancer. Arch Endocrinol Metab.
2019;63(2):95-6.). … in patients with papillary thyroid cancer. JAMA. 2013;309(14):1493-501.). …

Circulating Tumor DNA Harboring the BRAFV600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients

A Sato, M Tanabe, Y Tsuboi, T Niwa… - Thyroid, 2021 - liebertpub.com
Background: The significance of circulating tumor DNA (ctDNA) in primary papillary thyroid
cancer (PTC) is yet to be well established. This study aimed to clarify whether ctDNA carrying …

[HTML][HTML] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

J Ge, J Wang, H Wang, X Jiang, Q Liao, Q Gong… - … of Cancer, 2020 - ncbi.nlm.nih.gov
Thyroid cancer primarily includes the following four pathological … : papillary thyroid carcinoma,
follicular thyroid carcinoma, undifferentiated carcinoma and medullary thyroid carcinoma. …

BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm

JA Silver, M Bogatchenko… - … -Head & Neck …, 2021 - journals.sagepub.com
… The association of the BRAFV600E mutation with prognostic factors and poor clinical
outcome in papillary thyroid cancer: a meta-analysis Cancer 2012 118 7 1764 -1773 …

BRAF V600E and lymph node metastases in papillary thyroid cancer

P Chen, L Pan, W Huang, H Feng… - Endocrine …, 2020 - ec.bioscientifica.com
… Association between BRAF V600E mutation and mortality in patients with papillary thyroid
cancer. … Sancisi V, Nicoli D, Ragazzi M, Piana S & Ciarrocchi A BRAFV600E mutation does not …

Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience

S Kure, K Ishino, M Kudo, R Wada… - Journal of …, 2019 - journals.sagepub.com
… features and BRAF V600E status in all patients with papillary thyroid carcinoma. … the BRAF
V600E status and clinicopathological features in all patients with papillary thyroid carcinoma. …

[HTML][HTML] Relationship between BRAF V600E gene mutation and the clinical and pathologic characteristics of papillary thyroid microcarcinoma

W Ji, H Xie, B Wei, H Shen, A Liu, Y Gao… - International journal of …, 2019 - ncbi.nlm.nih.gov
Thyroid carcinoma is the most common endocrine malignancy, among which papillary thyroid
carcinoma (PTC) is the most common pathologic type, accounting for approximately 90% […